ON
← Back to feed
Life sciences investment giant to give Singapore medtech start-ups international boost
SG🏛️ Politicsyesterday

Life sciences investment giant to give Singapore medtech start-ups international boost

A new initiative called Sante Accel Singapore has been launched to support local medtech start-ups in Singapore by providing access to capital, venture-building talent, and global networks. The program is a collaboration between US-based Sante Ventures, which has significant experience in life sciences investing, and SG Growth Capital, part of Singapore's economic development agencies. The initiative aims to help start-ups navigate the complex process of clinical trials, regulatory approvals, and scaling their businesses internationally. Officials highlighted the growing demand for innovative medical technologies due to aging populations and advancements in personalized medicine. Singapore is already home to over 400 medtech companies and has seen substantial growth in its medtech manufacturing output, reaching $20.3 billion in 2024. The partnership is expected to enhance Singapore's position as a global leader in biomedical innovation.

3 reports

The Straits Times logoThe Straits TimesParty-aligned🔒Centeryesterday
S’pore, Timor-Leste to strengthen economic ties, bilateral exchanges: PM Wong

Singapore's Prime Minister Lawrence Wong and Timor-Leste's Prime Minister Xanana Gusmao signed an agreement to enhance economic ties and cooperation in areas like healthcare and education during Wong's first-ever visit to Timor-Leste. The pact establishes a regular consultation mechanism between the foreign ministries of both nations to address bilateral and regional issues. Singapore is already one of Timor-Leste's largest investors, with companies exploring opportunities in sectors such as renewable energy and wholesale trade. Starting in 2027, Singapore will open certain sectors to Timorese workers, allowing them to work in industries like construction and marine shipyards. This initiative aims to boost economic diversification and create new business opportunities while strengthening people-to-people connections.

Bias read (Center): The article presents a balanced account of the bilateral agreements and initiatives between Singapore and Timor-Leste, focusing on cooperative efforts and mutual benefits without overtly favoring either side. It reports on official statements and agreements without apparent ideological slant, thus t

The Straits Times logoThe Straits TimesParty-aligned🔒Centeryesterday
From F&B to aquaculture, S’poreans find opportunities for investment in Timor-Leste

The article discusses growing Singaporean investments in Timor-Leste across sectors such as food and beverage, construction, agriculture, and aquaculture. Julian Chiang, a Singaporean businessman operating in Timor-Leste, highlights the country's potential for development and mentions his company's involvement in supplying fuel and owning petrol stations. The piece notes Singapore Prime Minister Lawrence Wong's historic visit to Timor-Leste, marking the first by a Singaporean leader, and emphasizes strengthened bilateral ties. It also references Singapore's new resident embassy and ambassador, highlighting Singapore's influence through its diaspora and professional communities. Yap Kok Cheng, head of a Singapore-based firm, is mentioned as part of a joint venture in aquaculture.

Bias read (Center): The article presents a balanced view of Singapore's economic engagement with Timor-Leste, focusing on business opportunities and diplomatic relations without overtly favoring any political ideology. While it highlights Singapore's strategic interests and the significance of Prime Minister Wong's訪問,它

The Straits Times logoThe Straits TimesParty-aligned🔒Center4 days ago
Life sciences investment giant to give Singapore medtech start-ups international boost

A new initiative called Sante Accel Singapore has been launched to support local medtech start-ups in Singapore by providing access to capital, venture-building talent, and global networks. The program is a collaboration between US-based Sante Ventures, which has significant experience in life sciences investing, and SG Growth Capital, part of Singapore's economic development agencies. The initiative aims to help start-ups navigate the complex process of clinical trials, regulatory approvals, and scaling their businesses internationally. Officials highlighted the growing demand for innovative medical technologies due to aging populations and advancements in personalized medicine. Singapore is already home to over 400 medtech companies and has seen substantial growth in its medtech manufacturing output, reaching $20.3 billion in 2024. The partnership is expected to enhance Singapore's position as a global leader in biomedical innovation.

Bias read (Center): The article presents information about a public-private partnership aimed at supporting medtech innovation in Singapore. While the subject involves government initiatives and private investment, the framing remains neutral, focusing on the benefits of the collaboration without overtly favoring any政治

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories